Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD)

PHASE2CompletedINTERVENTIONAL
Enrollment

376

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions
Major Depressive Disorder (MDD)
Interventions
DRUG

MSI-195

DRUG

Placebo

Trial Locations (35)

10128

MSI Investigational Site, New York

14618

MSI Investigational Site, Rochester

21285

MSI Investigational Site, Towson

30328

MSI Investigational Site, Atlanta

32256

MSI Investigational Site, Jacksonville

32806

MSI Investigational Site, Orlando

33319

MSI Investigational Site, Lauderhill

34741

MSI INvestigational Site, Kissimmee

35216

MSI Investigational Site, Birmingham

38119

MSI Investigational Site, Memphis

39232

MSI Investigational Site, Flowood

44718

MSI Investigational Site, Canton

45417

MSI Investigational Site, Dayton

60169

MSI Investigational Site, Hoffman Estates

75231

MSI Investigational Site, Dallas

77008

MSI Investigational Site, Houston

77098

MSI Investigational Site, Houston

78731

MSI Investigational Site, Austin

78754

MSI Investigational Site, Austin

84123

MSI Investigational Site, Murray

87109

MSI Investigational Site, Albuquerque

89102

MSI Investigational Site, Las Vegas

90024

MSI Investigational Site, Los Angeles

90502

MSI Investigational Site, Torrance

90720

MSI Investigational Site, Los Alamitos

91316

MSI Investigational Site, Encino

91950

MSI Investigational Site, National City

92025

MSI Investigational Site, Escondido

92056

MSI Investigational Site, Oceanside

92660

MSI Investigational Site, Newport Beach

92845

MSI Investigational Site, Garden Grove

94612

MSI Investigational Site, Oakland

97210

MSI Investigational Site, Portland

98007

MSI Investigational Site, Bellevue

08053

MSI Investigational Site, Marlton

All Listed Sponsors
lead

MSI Methylation Sciences, Inc.

INDUSTRY

NCT01912196 - Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD) | Biotech Hunter | Biotech Hunter